Background illustration for clinical trials search

Paid Clinical Trials Arlington

Discover 1,917 paid clinical trials in Arlington, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Digoxin Medulloblastoma Study

for
Medulloblastoma, Medulloblastoma, Non-WNT/Non-SHH
Location: Dallas TX, Little Rock AR, St Louis MO, Birmingham AL,
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 1 - 30

Code: NCT06701812

Phase2, Recruiting

Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers

for
Anatomic Stage I Breast Cancer, Anatomic Stage II Breast Cancer,
Location: Dallas TX, Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18+

Code: NCT05919108

Phase2, Recruiting

Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.

for
Hematuria - Cause Not Known
Location: Dallas TX, Mobile AL, Homewood AL, Nashville TN,
Sponsor: Pacific Edge Limited

Sex: All

Age: 18 - 70+

Code: NCT06394869

Recruiting

A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue

for
Pediatric Sarcoma, Refractory, Pediatric Sarcoma, Relapsed
Location: Dallas TX, Houston TX, Little Rock AR, St Louis MO,
Sponsor: Nationwide Children's Hospital

Sex: All

Age: 2 - 40

Code: NCT05634369

Phase1, Phase2, Recruiting

CAR-T Long Term Follow Up (LTFU) Study

for
Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program,
Location: Dallas TX, Houston TX, Westwood KS, Kansas City MO,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 0 - 70+

Code: NCT02445222

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

for
Heart Failure, Heart Failure With Reduced Ejection Fraction
Location: Dallas TX, Plano TX, Houston TX, Tulsa OK, Galveston TX,
Sponsor: Cytokinetics

Sex: All

Age: 18 - 70+

Code: NCT06736574

Phase3, Recruiting

US National OCS Liver Perfusion (OLP) Registry

for
Liver Transplant
Location: Dallas TX, Houston TX, San Antonio TX, Saint Louis MO,
Sponsor: TransMedics

Sex: All

Age: 0+

Code: NCT05940857

Recruiting

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Dallas TX, Houston TX, San Antonio TX, Little Rock AR,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06297226

Phase2, Recruiting

Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

for
Relapsed or Refractory Acute Myeloid Leukemia (AML),
Location: Dallas TX, Houston TX, Charleston SC
Sponsor: Institut de Recherches Internationales Servier

Sex: All

Age: 18+

Code: NCT02074839

Phase1, Recruiting

A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer

for
Prostate Cancer, Prostate Adenocarcinoma
Location: Dallas TX, Chicago IL, Portland OR
Sponsor: University of Chicago

Sex: Male

Age: 18+

Code: NCT05726292

Phase2, Recruiting

Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk

for
Liver Fibroses, Cirrhosis
Location: Dallas TX, Boston MA
Sponsor: Raymond Chung

Sex: All

Age: 18+

Code: NCT05028829

Phase2, Recruiting

Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD)

for
FSHD
Location: Dallas TX, Austin TX, Kansas City KS, Aurora CO,
Sponsor: University of Kansas Medical Center

Sex: All

Age: 0+

Code: NCT04635891

Recruiting

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

for
Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma,
Location: Dallas TX, Houston TX, Columbus OH, Canton OH,
Sponsor: OncoNano Medicine, Inc.

Sex: All

Age: 18+

Code: NCT06022029

Phase1, Recruiting

Study in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

for
Heart Failure With Preserved Ejection Fraction (HFpEF)
Location: Dallas TX
Sponsor: Secretome Therapeutics

Sex: All

Age: 18+

Code: NCT06560762

Phase1, Recruiting

Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

for
Lower Respiratory Tract Infection, Parainfluenza,
Location: Dallas TX, Oklahoma City OK, Houston TX, Fairway KS,
Sponsor: Ansun Biopharma, Inc.

Sex: All

Age: 0+

Code: NCT03808922

Phase3, Recruiting

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

for
Superficial Bladder Cancer,
Location: Dallas TX, Austin TX, Houston TX, Little Rock AR,
Sponsor: enGene, Inc.

Sex: All

Age: 18+

Code: NCT04752722

Phase1, Phase2, Recruiting

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

for
Geographic Atrophy, Macular Degeneration
Location: Dallas TX, Willow Park TX, Austin TX, The Woodlands TX,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 60+

Code: NCT06635148

Phase2, Phase3, Recruiting

4D-710 in Adult Patients With Cystic Fibrosis

for
Cystic Fibrosis Lung
Location: Dallas TX, Kansas City KS, Birmingham AL, Denver CO,
Sponsor: 4D Molecular Therapeutics

Sex: All

Age: 18+

Code: NCT05248230

Phase2, Recruiting

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

for
Non-Muscle Invasive Bladder Cancer
Location: Dallas TX, Austin TX, Houston TX, Wichita KS,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06319820

Phase3, Recruiting

Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study

for
Advanced Clear Cell Renal Cell Carcinoma,
Location: Dallas TX, Nashville TN, Cleveland OH, Orange CA,
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18+

Code: NCT05361720

Phase2, Recruiting